This is an archive for Capital Mind Premium subscribers, sent on 14th December 2013.
The Case of Strides Arcolab
Strides Arcolab recently sold it’s Agila Specialties division to Mylan for $1.75 billion. They will now use the money to cut out short term debt and distribute $525 million to shareholders, which translates to Rs. 500 per share. (They have about 6 crore shares)
The rest of this content is only available to premium members.
Register for a premium membership today! Apart from this content you will get our proprietary research and weekly newsletter too!
Already a subscriber? Log in now!